Exchange: OTC·Updated 12:29 PM EDT
About APTN
Adaptin Bio, Inc. engages in the development and commercialization of products by utilizing novel technology that delivers drugs and other compounds to the brain and other tissues. It operates through its proprietary platform technology called BRiTE (Brain Bispecific T-cell Engager). The company was founded by Michael J. Roberts in 2021 and is headquartered in Charlotte, NC.